Maxigen Biotech (TPE:1783) Beneish M-Score : 12.74 (As of May. 19, 2024)

View and export this data going back to 2011. Start your Free Trial

What is Maxigen Biotech Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Warning Sign:

Beneish M-Score 12.74 higher than -1.78, which implies that the company might have manipulated its financial results.

The historical rank and industry rank for Maxigen Biotech's Beneish M-Score or its related term are showing as below:

TPE:1783' s Beneish M-Score Range Over the Past 10 Years
Min: -3.89 Med: -2.44 Max: 12.74
Current: 12.74

During the past 13 years, the highest Beneish M-Score of Maxigen Biotech was 12.74. The lowest was -3.89. And the median was -2.44.

Maxigen Biotech Beneish M-Score Historical Data

The historical data trend for Maxigen Biotech's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Maxigen Biotech Beneish M-Score Chart

Maxigen Biotech Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Beneish M-Score

Get a 7-Day Free Trial

-2.52

-2.26

-2.80

-3.11

5.87

Maxigen Biotech Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Beneish M-Score	Get a 7-Day Free Trial															-3.01	7.81	8.92	5.87	12.74

Competitive Comparison of Maxigen Biotech's Beneish M-Score

For the Medical Instruments & Supplies subindustry, Maxigen Biotech's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Maxigen Biotech's Beneish M-Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Maxigen Biotech's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Maxigen Biotech's Beneish M-Score falls into.

Maxigen Biotech Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Maxigen Biotech for today is based on a combination of the following eight different indices:

-4.84

0.92 * DSRI

0.528 * GMI

0.404 * AQI

0.892 * SGI

0.115 * DEPI

-4.84

0.92 * 0.7682

0.528 * 0.9471

0.404 * 39.7921

0.892 * 0.9711

0.115 * 1.0289

0.172 * SGAI

4.679 * TATA

0.327 * LVGI

0.172 * 1.2972

4.679 * -0.034298

0.327 * 0.921

12.74

This Year (Mar24) TTM:

Last Year (Mar23) TTM:

Total Receivables was NT$83.8 Mil.
Revenue was 127.058 + 148.742 + 159.427 + 170.919 = NT$606.1 Mil.
Gross Profit was 87.75 + 102.558 + 108.623 + 116.219 = NT$415.2 Mil.
Total Current Assets was NT$655.1 Mil.
Total Assets was NT$1,489.8 Mil.
Property, Plant and Equipment(Net PPE) was NT$430.6 Mil.
Depreciation, Depletion and Amortization(DDA) was NT$27.2 Mil.
Selling, General, & Admin. Expense(SGA) was NT$200.5 Mil.
Total Current Liabilities was NT$136.0 Mil.
Long-Term Debt & Capital Lease Obligation was NT$0.0 Mil.
Net Income was 28.416 + 17.664 + 41.366 + 62.349 = NT$149.8 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = NT$0.0 Mil.
Cash Flow from Operations was 53.955 + 56.824 + 17.448 + 72.664 = NT$200.9 Mil.

Total Receivables was NT$112.4 Mil.
Revenue was 143.027 + 164.307 + 162.637 + 154.226 = NT$624.2 Mil.
Gross Profit was 96.694 + 109.852 + 107.742 + 90.591 = NT$404.9 Mil.
Total Current Assets was NT$1,047.1 Mil.
Total Assets was NT$1,492.2 Mil.
Property, Plant and Equipment(Net PPE) was NT$435.0 Mil.
Depreciation, Depletion and Amortization(DDA) was NT$28.4 Mil.
Selling, General, & Admin. Expense(SGA) was NT$159.2 Mil.
Total Current Liabilities was NT$147.9 Mil.
Long-Term Debt & Capital Lease Obligation was NT$0.0 Mil.

1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI	=	(Receivables_t / Revenue_t)	/	(Receivables_t-1 / Revenue_t-1)
	=	(83.848 / 606.146)	/	(112.392 / 624.197)
	=	0.13833	/	0.180059
	=	0.7682

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI	=	GrossMargin_t-1	/	GrossMargin_t
	=	(GrossProfit_t-1 / Revenue_t-1)	/	(GrossProfit_t / Revenue_t)
	=	(404.879 / 624.197)	/	(415.15 / 606.146)
	=	0.64864	/	0.684901
	=	0.9471

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI	=	(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t)	/	(1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
	=	(1 - (655.139 + 430.556) / 1489.75)	/	(1 - (1047.118 + 434.96) / 1492.249)
	=	0.271223	/	0.006816
	=	39.7921

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI	=	Sales_t	/	Sales_t-1
	=	Revenue_t	/	Revenue_t-1
	=	606.146	/	624.197
	=	0.9711

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI	=	(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1))	/	(Depreciation_t / (Depreciaton_t + PPE_t))
	=	(28.371 / (28.371 + 434.96))	/	(27.245 / (27.245 + 430.556))
	=	0.061233	/	0.059513
	=	1.0289

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI	=	(SGA_t / Sales_t)	/	(SGA_t-1 /Sales_t-1)
	=	(200.541 / 606.146)	/	(159.205 / 624.197)
	=	0.330846	/	0.255056
	=	1.2972

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI	=	((LTD_t + CurrentLiabilities_t) / TotalAssets_t)	/	((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
	=	((0 + 135.991) / 1489.75)	/	((0 + 147.901) / 1492.249)
	=	0.091284	/	0.099113
	=	0.921

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA	=	(IncomefromContinuingOperations_t	-	CashFlowsfromOperations_t)	/	TotalAssets_t
	=	(NetIncome_t - NonOperatingIncome_t	-	CashFlowsfromOperations_t)	/	TotalAssets_t
	=	(149.795 - 0	-	200.891)	/	1489.75
	=	-0.034298

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Maxigen Biotech has a M-score of 12.74 signals that the company is likely to be a manipulator.

Maxigen Biotech Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Maxigen Biotech's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.

Maxigen Biotech (TPE:1783) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Maxigen Biotech Inc (TPE:1783) » Definitions » Beneish M-Score

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 88, Keji 1st Rd, Guishan District, Taoyuan City, TWN, 333

Website

https://www.mbi.com.tw

Maxigen Biotech Inc specializes in the developing, manufacturing, and marketing of biomedical and cosmeceutical skincare products. It provides medical devices for orthopedic, ophthalmic, dental, and surgical applications. Skincare product categories include mask series, facial cleansing series, and body care series. The biomedical products segment is primarily engaged in the manufacturing and sales of collagen and bone materials, which forms the majority chunk of the revenue of the group. The consumer products segment is engaged in the manufacturing and sales of beauty care products.

Maxigen Biotech (TPE:1783) Headlines

No Headlines